Enroll now

Nailvision provides a telemedical diagnosis and personalized therapy platform for 20 million patients in Germany suffering from nail disorders.

#Endlich barfuß #DigitalDermatology #NailDiseases #telemedicine
learn more
nailvision team

What our founder think:

We are impacting the world by….

12 Mio. patients in Germany suffer from nail diseases with a psychological burden.

We are convinced that the world in the next 5 years …

medicine will be full of innovations, the potential is huge and the eRezept will finally work.

REAKTOR.BERLIN enables us to…

get business insights, connect with experienced mentors, get in contact with VCs & angels.

About:

Nailvision uses AI & Telemedicine to fuel a patient smartphone app that enables patients with nail & skin disorders to receive the best possible treatment. 1 in 4 people globally have a nail disorders and treatments last at least a year with less than 20% cure rates and 50% misdiagnosis. With Nailvision they receive an accurate diagnosis.We offer a telemedicine solution where patients can get help with their nail or skin problem. Initially in the diagnosis of the problem, later in the therapy of the problem.The business model: Nailvision earns money by referrals to doctors, who save time thanks to the telemedicine solution. Nailvision continues to make money from the drugs sold and the therapy solution.

Founder team

Markus Hinsche

Markus Hinsche

CTO

Nataniel Müller

Nataniel Müller

CEO/COO

Industry

AI, Healthcare

Find out more

Link Linkedin-in

We help you thrive. Let's Do or Do!

Enroll now
Find out more
Navigation
Legal
supported by:
Berlin
Kofinanziert von der Europäischen Union_POS
Reaktor.Berlin Logo weiß

©2023 Reaktor.Berlin. All rights reserved.

Linkedin Youtube Eventbrite Icon Envelope